Paul M. Bisaro

Former Senior Consultant at Arthur Andersen LLP

Paul M. Bisaro

Paul M. Bisaro

Former Senior Consultant at Arthur Andersen LLP

Overview
Career Highlights

Barr Pharmaceuticals, Inc.
Barr Laboratories, Inc.
Teva Women's Health, Inc.

RelSci Relationships

2444

Number of Boards

15

Birthday

1961

Age

59

Number of Awards

3

Relationships
RelSci Relationships are individuals Paul M. Bisaro likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman, President & Chief Executive Officer at The Allergan Foundation

Relationship likelihood: Strong

Chief Executive Officer & Director at Tanvex Biopharma, Inc.

Relationship likelihood: Strong

Former President, Chief Executive Officer & Director at Amneal Pharmaceuticals, Inc.

Relationship likelihood: Strong

Advisory Partner at NewSpring Capital

Relationship likelihood: Strong

President at Tamarack Bay LLC

Relationship likelihood: Strong

Founder at Nettleton Advisors LLC

Relationship likelihood: Strong

Managing Director at FGW Consultancy LLC

Relationship likelihood: Strong

Former Senior Corporate Counsel, Corporate Counsel & Assistant Secretary at Actavis, Inc.

Relationship likelihood: Strong

Chief Financial Officer at Dun & Bradstreet, Inc.

Relationship likelihood: Strong

Former Chief Operating Officer & Senior Vice President at Actavis, Inc.

Relationship likelihood: Strong

Paths to Paul M. Bisaro
Potential Connections via
Relationship Science
You
Paul M. Bisaro
Former Senior Consultant at Arthur Andersen LLP
Education
Juris Doctor
Class of 1989

The Columbus School of Law, also known as CUA Law, is the law school of The Catholic University of America, in Washington, D.C. The law school was established in 1897. Its name comes from ties to The Knights of Columbus.

Undergraduate in General Studies
Class of 1983

The University of Michigan (UM, U-M, UMich, or U of M), frequently referred to as simply Michigan, is a public research university located in Ann Arbor, Michigan, United States. It is the state's oldest university and the flagship campus of the University of Michigan. It is one of the original eight Public Ivy universities and is one of the founding members of the Association of American Universities. It has been ranked among the top five research universities in the US, and among the top 20 universities in the world. U-M also has satellite campuses in Flint and Dearborn.

JD Unknown

The Catholic University of America (CUA) is a private university located in Washington, D.C. in the United States. It is a pontifical university of the Catholic Church in the United States and the only institution of higher education founded by the U.S. Catholic bishops. Established in 1887 as a graduate and research center following approval by Pope Leo XIII on Easter Sunday, the university began offering undergraduate education in 1904. It has been called one of the 25 most underrated colleges in America, one of the nation's best colleges by the Princeton Review, "one of the most eco-friendly universities in the country," and has been recommended by the Cardinal Newman Society.

Career History
President, Chief Executive Officer & Director
2017 - 2018

Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ.

Senior Consultant
Tenure Unconfirmed

Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL.

President, Chief Executive Officer & Director
Prior - 2019

Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.

Boards & Committees
Executive Chairman
Prior - 2014

Forest has well-established franchises in multiple therapeutic areas, and we are always exploring new product opportunities that address a range of health conditions. Our principal brands include Bystolic® (nebivolol), Daliresp® (roflumilast), Lexapro® (escitalopram oxalate), Linzess™ (linaclotide), Namenda® (memantine HCl), Savella®(milnacipran HCl), Teflaro® (ceftaroline fosamil) for injection, Tudorza™ Pressair™ (aclidinium bromide inhalation powder), and Viibryd® (vilazodone HCl). Forest identifies, develops, and delivers pharmaceutical products that make a difference in people's lives. We have been extremely successful in meeting our business objectives and expanding our franchises, but we also derive satisfaction in helping to bring relief to people who are suffering. We credit our success to our innovation, integrity, and commitment to developing important products

Political Donations
$1,000
2006

President & Chief Executive Officer at Business Industry Political Action Committee

$1,000
2006

Representative from Ohio's 10th Congressional District

$1,000
2006

Former Partner at Bird, Kinder and Huffman

Transactions
Details Hidden

Allergan Plc purchases Forest Laboratories, Inc.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
Rank #219
2014
Chief Executive Magazine - Wealth Creators
Rank #31
2014
Harvard Business Review - 100 Best-Performing CEOs in the World
Rank #57
2013
Chief Executive Magazine - Wealth Creators
Events
Speaker
New York City, NY
2013 UBS Global Healthcare Conference

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Paul M. Bisaro. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Paul M. Bisaro's profile does not indicate a business or promotional relationship of any kind between RelSci and Paul M. Bisaro.